Literature DB >> 24055304

Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.

Philippe Duclos1, Laure Dumolard, Nihal Abeysinghe, Alex Adjagba, Cara Bess Janusz, Richard Mihigo, Liudmila Mosina, Yashohiro Takashima, Murat Hakan Oztürk.   

Abstract

The majority of industrialized and some developing countries have established National Immunization Technical Advisory Groups (NITAGs). To enable systematic global monitoring of the existence and functionality of NITAGs, in 2011, WHO and UNICEF included related questions in the WHO/UNICEF Joint Reporting Form (JRF) that provides an official means to globally collect indicators of immunization program performance. These questions relate to six basic process indicators. According to the analysis of the 2013 JRF, data for 2012, notable progress was achieved between 2010 and 2012 and by the end of 2012, 99 countries (52%) reported the existence of a NITAG with a formal legislative or administrative basis (with a high of 86% in the Eastern Mediterranean Region - EMR), among the countries that reported data in the NITAG section of the JRF. There were 63 (33%) countries with a NITAG that met six process indicators (47% increase over the 43 reported in 2010) including a total of 38 developing countries. 11% of low income countries reported a NITAG that meets all six process criteria, versus 29% of middle income countries and 57% of the high income ones. Countries with smaller populations reported the existence of a NITAG that meets all six process criteria less frequently than more populated countries (23% for less populated countries versus 43% for more populated ones). However, progress needs to be accelerated to reach the Global Vaccine Action Plan (GVAP) target of ensuring all countries have support from a NITAG. The GVAP represents a major opportunity to boost the institutionalization of NITAGs. A special approach needs to be explored to allow small countries to benefit from sub-regional or other countries advisory groups.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  AFR; AMR; African Region; CDC; Centers for Disease Control and Prevention; Decade of Vaccines; DoV; EMR; EUR; Eastern Mediterranean Region; European Region; Evidence-based decision making; GVAP; Global Vaccine Action Plan; JRF; Joint Reporting Form; Monitoring; NITAG; National Immunization Technical Advisory Group; National Immunization Technical Advisory Group (NITAG); Region of the Americas; SEAR; SIVAC; South-East Asia Region; Supporting Independent Immunization and Vaccine Advisory Committees; UNICEF; United Nations Children's Fund; WHA; WHO; WHO/UNICEF Joint Reporting Form; WPR; Western Pacific Region; World Health Assembly; World Health Organization

Mesh:

Year:  2013        PMID: 24055304     DOI: 10.1016/j.vaccine.2013.08.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Fifty Years of Global Immunization at CDC, 1966-2015.

Authors:  Eric E Mast; Stephen L Cochi; Olen M Kew; K Lisa Cairns; Peter B Bloland; Rebecca Martin
Journal:  Public Health Rep       Date:  2016-12-19       Impact factor: 2.792

2.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

3.  The future of routine immunization in the developing world: challenges and opportunities.

Authors:  Angela K Shen; Rebecca Fields; Mike McQuestion
Journal:  Glob Health Sci Pract       Date:  2014-12-10

4.  Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns.

Authors:  Melanie Marti; Monica de Cola; Noni E MacDonald; Laure Dumolard; Philippe Duclos
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

5.  The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs.

Authors:  Antoinette Ba-Nguz; Alex Adjagba; Toto Wisnu Hendrarto; Nelson K Sewankambo; Celia Nalwadda; Annette Kisakye
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.

Authors:  Alex Adjagba; Noni E MacDonald; Inmaculada Ortega-Pérez; Philippe Duclos
Journal:  Vaccine       Date:  2017-04-26       Impact factor: 3.641

7.  Questions for future evidence-informed policy initiatives: insights from the evolution and aspirations of National Immunization Technical Advisory Groups.

Authors:  Anne L Buffardi; Susan Njambi-Szlapka
Journal:  Health Res Policy Syst       Date:  2020-04-22

8.  The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.

Authors:  Natasha Howard; Helen Walls; Sadie Bell; Sandra Mounier-Jack
Journal:  Vaccine       Date:  2018-07-31       Impact factor: 3.641

9.  Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committees.

Authors:  Sharon A Greene; Blanche-Philomene Melanga Anya; Humayun Asghar; Irtaza A Chaudhri; S Deblina Datta; Morgane E Donadel; Koffi Isidore Kouadio; Abigail M Shefer; Kathleen F Cavallaro
Journal:  Health Res Policy Syst       Date:  2020-10-06

10.  Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.

Authors:  Noni E MacDonald; Philippe Duclos; Ole Wichmann; Louise Henaff; Anthony Harnden; Aisha Alshammary; Roberto Arroba Tijerino; Madeline Hall; Jahit Sacarlal; Rupa Rajbhandari Singh
Journal:  Vaccine       Date:  2017-11-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.